ATE142642T1 - Hirudinanalog oder dessen salz, dessen herstellung und das als aktiven bestandteil enthaltende antikoagulanz - Google Patents

Hirudinanalog oder dessen salz, dessen herstellung und das als aktiven bestandteil enthaltende antikoagulanz

Info

Publication number
ATE142642T1
ATE142642T1 AT92905744T AT92905744T ATE142642T1 AT E142642 T1 ATE142642 T1 AT E142642T1 AT 92905744 T AT92905744 T AT 92905744T AT 92905744 T AT92905744 T AT 92905744T AT E142642 T1 ATE142642 T1 AT E142642T1
Authority
AT
Austria
Prior art keywords
glu
tyr
active ingredient
salt
production
Prior art date
Application number
AT92905744T
Other languages
English (en)
Inventor
Ryo Muramatsu
Akiko Sukesada
Satoru Misawa
Eriko Nikui
Koichi Wada
Masaharu Nakano
T Morikawa
Kyoichi Hasumachi Kobashi
Original Assignee
Japan Energy Corp
Fuji Yakuhin Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Energy Corp, Fuji Yakuhin Kogyo Kk filed Critical Japan Energy Corp
Application granted granted Critical
Publication of ATE142642T1 publication Critical patent/ATE142642T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Electrotherapy Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT92905744T 1991-03-05 1992-03-04 Hirudinanalog oder dessen salz, dessen herstellung und das als aktiven bestandteil enthaltende antikoagulanz ATE142642T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6390991 1991-03-05

Publications (1)

Publication Number Publication Date
ATE142642T1 true ATE142642T1 (de) 1996-09-15

Family

ID=13242934

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92905744T ATE142642T1 (de) 1991-03-05 1992-03-04 Hirudinanalog oder dessen salz, dessen herstellung und das als aktiven bestandteil enthaltende antikoagulanz

Country Status (7)

Country Link
EP (1) EP0531537B1 (de)
AT (1) ATE142642T1 (de)
AU (1) AU660171B2 (de)
CA (1) CA2081305A1 (de)
DE (1) DE69213628T2 (de)
FI (1) FI924937A (de)
WO (1) WO1992015610A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2687681B1 (fr) * 1992-02-20 1995-10-13 Transgene Sa Conjugues polyethyleneglycol-hirudine, leur procede de preparation et leur emploi pour le traitement des thromboses.
DE50215004D1 (de) 2001-09-10 2011-05-26 Novel Science Internat Gmbh Organische verbindungen mit biologischer wirkung als thrombinhemmer und ihre verwendung
CN113789293B (zh) * 2021-11-16 2022-03-15 江苏省中国科学院植物研究所 一种高产天然水蛭素的大肠杆菌工程菌株及其应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341032C (en) * 1987-01-23 2000-06-20 John L. Krstenansky Anticoagulant peptides
JPH04503660A (ja) * 1988-12-05 1992-07-02 バイオジェン インコーポレイテッド 血小板凝集抑制の方法及び組成物
AU6070590A (en) * 1989-07-20 1991-02-22 Biogen, Inc. Hirudin peptide derivatives
ZA907742B (en) * 1989-10-03 1991-07-31 Merrell Dow Pharma Anticoagulant peptides
CA2035917C (en) * 1990-02-13 2001-10-02 John L. Krstenansky Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin

Also Published As

Publication number Publication date
FI924937A0 (fi) 1992-10-30
EP0531537A4 (de) 1992-12-30
CA2081305A1 (en) 1992-09-06
WO1992015610A1 (fr) 1992-09-17
DE69213628D1 (de) 1996-10-17
AU660171B2 (en) 1995-06-15
EP0531537A1 (de) 1993-03-17
FI924937A (fi) 1992-10-30
DE69213628T2 (de) 1997-04-24
EP0531537B1 (de) 1996-09-11
AU1361692A (en) 1992-10-06

Similar Documents

Publication Publication Date Title
ATE103914T1 (de) Neue thienylcarbonsaeureester von aminoalkoholen, ihre quaternierungsprodukte sowie die herstellung und verwendung dieser verbindungen.
ATA195588A (de) Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu
IT7826758A0 (it) Microorganismi e procedimento per nuove preparazioni dila loro produzione, come pure l'impiego delle stesse per la decomposizione di prodotti industriali organici di sintesi.
KR890011606A (ko) 항응고제
DE68909077D1 (de) Gamma-Linolensäure oder Dihomo-gamma-Linolensäure enthaltende Zubereitung zur Verbesserung der Haut.
ES2024641B3 (es) Preservativo.
FI885454A0 (fi) Administrationssystem, som laongsamt frigoer substituerade dihydropyridiner.
DE3475714D1 (en) Griseolic acid derivatives, and their use
ES2169272T3 (es) Diaminopirimidinas, composiciones farmaceuticas que las contienen y su utilizacion como agente antibacteriano.
ATE81980T1 (de) Pharmazeutisches kombinationspraeparat sowie dessen herstellung und verwendung.
ES2055163T3 (es) Utilizacion del cofactor-enzima nadph para la preparacion de un medicamento asi como el medicamento preparado de este modo y procedimiento para su preparacion.
ATE33253T1 (de) Verfahren zur herstellung von reinen dermatansulfat- und herapansulfatglykosaminoglukanen und ihre pharmazeutische verwendung.
ATE142642T1 (de) Hirudinanalog oder dessen salz, dessen herstellung und das als aktiven bestandteil enthaltende antikoagulanz
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
ES2071143T3 (es) Factores b1, b2, c1, c2, d1, d2, e y t del antibiotico ge 2270.
DK0391185T3 (da) 1,8-Naphthyridiner
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
ATE266413T1 (de) Verwendung von neotrehalose zur herstellung eines medikaments zur energiesupplementierung bei einem lebenden organismus
IT8919524A0 (it) Derivati dal 1 arilsolfonil 2 piperidone, loro procedimento di preparazione e loro impiego come farmaci.
DE3670491D1 (de) Pyrazinderivate, verfahren zu deren herstellung und pharmazeutische zusammensetzungen mit diesen.
NO924241L (no) Hirudinanalog eller salt derav, fremstilling derav, og antikoagulant inneholdende den samme som aktiv bestanddel
SE8802193L (sv) Utvaertes anvaendbar, antiviral farmaceutisk komposition som ackumuleras i huden samt foerfarande foer framsttaellning av densamma
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.
SE8802323L (sv) 8alfa-acylaminoergolin, dess framstaellning samt farmaceutiska kompositioner innehaallande detsamma

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties